Intellia Therapeutics

5 followers


Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

John Leonard
President & CEO

John Leonard

Collapse
Eliana Clark
EVP, CTO
David Lebwohl
EVP, Chief Medical Officer
Derek Hicks
EVP, Chief Business Officer
Laura Sepp-Lorenzino
EVP, Chief Scientific Officer
James Basta
EVP, General Counsel & Corporate Secretary
Aron Stein
SVP, Regulatory Affairs
Marika St. Amand
SVP, Chief Human Resources Officer
Mary Ferguson
Senior Vice President, Head of Intellectual Property
Ian Karp
SVP, Investor Relations and Corporate Communications
Yuanxin Xu
SVP, Early Development & Transitional Medicine